Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 2, single-arm study of bempegaldesleukin (NKTR-214) in combination with nivolumab in cisplatin ineligible, locally advanced or metastatic urothelial cancer patients
Pook, David
(Primary Chief Investigator (PCI))
Medicine Monash Health
Anatomy & Developmental Biology
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
24/06/19
→
23/06/24
View all
View less
Keywords
clinical trial
treatment efficacy
urothelial cancer
phase 2 study